share_log

BTIG Maintains Buy on Mustang Bio, Lowers Price Target to $16

Benzinga ·  Aug 15, 2023 11:32

BTIG analyst Justin Zelin maintains Mustang Bio (NASDAQ:MBIO) with a Buy and lowers the price target from $20 to $16.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment